Literature DB >> 12701836

Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment.

R Singla1, M M Osman, N Khan, N Al-Sharif, M O Al-Sayegh, M A Shaikh.   

Abstract

SETTING: Studies have shown that adverse outcomes are more likely in patients showing persistent sputum positivity at the end of 2 months of anti-tuberculosis treatment.
OBJECTIVE: To identify simple clinical, microbiological or radiological factors associated with persistent sputum positivity under national programme conditions.
DESIGN: Sputum smear-positive pulmonary tuberculosis patients admitted in 2 consecutive years to a referral hospital, and who received standard short-course chemotherapy under direct observation, were reviewed retrospectively. Factors associated with persistent sputum smear positivity were analysed.
RESULTS: A total of 514 patients were available for review. Logistic regression analysis showed that age groups 41-60 years and more than 60 years, numerous bacilli on initial sputum smear examination, and presence of multiple cavitary diseases were significant factors associated with persistent sputum positivity at the end of 2 months of treatment (P < 0.0001).
CONCLUSIONS: Identification of high risk factors associated with persistent sputum positivity, such as specific age groups, numerous bacilli on initial sputum smear examination, and presence of multiple cavitary diseases, may be helpful in stratifying the patients according to the risk of adverse outcome, thus allowing greater efficiency in resource utilisation.

Entities:  

Mesh:

Year:  2003        PMID: 12701836

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  31 in total

1.  Sex-related trends in non-conversion of new smear-positive tuberculosis patients in the Free State, South Africa.

Authors:  J C Heunis; N G Kigozi; S van der Merwe; P Chikobvu; N Beyers
Journal:  Public Health Action       Date:  2014-03-21

2.  Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka.

Authors:  W Jayakody; A D Harries; S Malhotra; S de Alwis; S Samaraweera; N Pallewatta
Journal:  Public Health Action       Date:  2013-03-21

3.  Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.

Authors:  F Qazi; U Khan; S Khowaja; M Javaid; A Ahmed; N Salahuddin; H Hussain; M C Becerra; J E Golub; A J Khan
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

4.  Profile of tuberculosis patients with delayed sputum smear conversion in the Pacific island of Vanuatu.

Authors:  S Fanai; K Viney; L Tarivonda; C Roseveare; M Tagaro; B J Marais
Journal:  Public Health Action       Date:  2014-06-21

5.  The factors associated with tuberculosis recurrence in the northwest and west of iran.

Authors:  Leyla Sahebi; Khalil Ansarin; Seyyedi Maryam; Amir Monfaredan; Hamed Sabbgh Jadid
Journal:  Malays J Med Sci       Date:  2014 Nov-Dec

6.  The effect of diabetic control status on the clinical features of pulmonary tuberculosis.

Authors:  S W Park; J W Shin; J Y Kim; I W Park; B W Choi; J C Choi; Y S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

7.  How soon should patients with smear-positive tuberculosis be released from inpatient isolation?

Authors:  David J Horne; Catherine O Johnson; Eyal Oren; Christopher Spitters; Masahiro Narita
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

8.  A study of sputum conversion in new smear positive pulmonary tuberculosis cases at the monthly intervals of 1, 2 & 3 month under directly observed treatment, short course (dots) regimen.

Authors:  S Bawri; S Ali; C Phukan; B Tayal; P Baruwa
Journal:  Lung India       Date:  2008-07

9.  Smoking and 2-month culture conversion during anti-tuberculosis treatment.

Authors:  E L Maciel; A P Brioschi; R L Peres; L M Guidoni; F K Ribeiro; D J Hadad; S A Vinhas; E Zandonade; M Palaci; R Dietze; J L Johnson
Journal:  Int J Tuberc Lung Dis       Date:  2013-02       Impact factor: 2.373

10.  A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

Authors:  Fiona Young; Julia A Critchley; Lucy K Johnstone; Nigel C Unwin
Journal:  Global Health       Date:  2009-09-14       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.